Xenetic Biosciences, Inc. (XBIO) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 7.6M | 8.05M | 5.07M | 5.35M | 5.48M | 6.59M | 7.03M | 8.01M | 8.38M | 9.59M | 11.26M | 12.04M | 12.87M | 13.65M | 14.17M | 15.38M | 16.89M | 18.72M | 20.58M | 10.2M |
| Cash & Short-Term Investments | 7.35M | 7.88M | 4.12M | 4.78M | 5.16M | 6.17M | 6.84M | 7.3M | 7.82M | 8.98M | 9.78M | 10.73M | 11.99M | 13.1M | 13.85M | 14.93M | 16.16M | 18.24M | 19.7M | 9.28M |
| Cash Only | 7.35M | 7.88M | 4.12M | 4.78M | 5.16M | 6.17M | 6.84M | 7.3M | 7.82M | 8.98M | 9.78M | 10.73M | 11.99M | 13.1M | 13.85M | 14.93M | 16.16M | 18.24M | 19.7M | 9.28M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 716.38K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | 89.74 | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 247.81K | 166.29K | 946.36K | 573.85K | 70K | 0 | 188.09K | 0 | 229K | 603.83K | 1.48M | 1.32M | 476.54K | 0 | 0 | 9.61K | 217.57K | 227.04K | 636.33K | 737.41K |
| Total Non-Current Assets | 313.92K | 313.92K | 0 | 0 | 313.92K | 313.92K | 1.02M | 1.02M | 1.02M | 1.02M | 704.43K | 704.43K | 844.43K | 1.07M | 1.41M | 1.09M | 1.09M | 1.09M | 704.43K | 715.9K |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.96K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 22.54x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 200K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 313.92K | 313.92K | 0 | 0 | 313.92K | 313.92K | 1.02M | 1.02M | 1.02M | 1.02M | 704.43K | 704.43K | 644.43K | 1.07M | 1.41M | 1.09M | 1.09M | 1.09M | 704.43K | 707.94K |
| Total Assets | 7.91M | 8.36M | 5.07M | 5.35M | 5.79M | 6.9M | 8.05M | 9.03M | 9.39M | 10.61M | 11.96M | 12.75M | 13.72M | 14.72M | 15.57M | 16.47M | 17.98M | 19.82M | 21.29M | 10.92M |
| Asset Turnover | 0.10x | 0.11x | 0.20x | 0.11x | 0.09x | 0.09x | 0.07x | 0.08x | 0.05x | 0.06x | 0.05x | 0.05x | 0.04x | 0.03x | 0.03x | 0.02x | 0.02x | 0.02x | 0.02x | 0.03x |
| Asset Growth % | 36.57% | 21.19% | -37.01% | -40.73% | -38.35% | -34.92% | -32.73% | -29.15% | -31.51% | -27.96% | -23.19% | -22.58% | -23.73% | -25.71% | -26.84% | 50.87% | 52.9% | 50.35% | 144.76% | -42.74% |
| Total Current Liabilities | 958.24K | 968.02K | 1.11M | 903.43K | 667.93K | 894.26K | 1.01M | 1.59M | 716.49K | 809.59K | 1.07M | 871.32K | 856.37K | 1.07M | 1.05M | 1.28M | 1.06M | 1.42M | 1.12M | 958.21K |
| Accounts Payable | 558.81K | 258.11K | 578.25K | 346.83K | 240.29K | 283.62K | 243.34K | 283.59K | 210.48K | 240.83K | 448.56K | 221.28K | 259.18K | 287.36K | 202.78K | 472.7K | 280.68K | 362.47K | 248.49K | 305.09K |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.91K | - | - | 3.03K | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 399.43K | 709.92K | 0 | 0 | 0 | 34.2K | 0 | 0 | 0 | 48.26K | 0 | 0 | 597.18K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio | 7.93x | 8.32x | 4.56x | 5.93x | 8.20x | 7.37x | 6.96x | 5.05x | 11.69x | 11.84x | 10.54x | 13.82x | 15.03x | 12.72x | 13.48x | 12.02x | 15.88x | 13.18x | 18.35x | 10.64x |
| Quick Ratio | 7.93x | 8.32x | 4.56x | 5.93x | 8.20x | 7.37x | 6.96x | 5.05x | 11.69x | 11.84x | 10.54x | 13.82x | 15.03x | 12.72x | 13.48x | 12.02x | 15.88x | 13.18x | 18.35x | 10.64x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.96K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.96K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 958.24K | 968.02K | 1.11M | 903.43K | 667.93K | 894.26K | 1.01M | 1.59M | 716.49K | 809.59K | 1.07M | 871.32K | 856.37K | 1.07M | 1.05M | 1.28M | 1.06M | 1.42M | 1.12M | 966.17K |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.61K | 17.57K | 27.04K | 36.33K | 45.37K |
| Net Debt | -7.35M | -7.88M | -4.12M | -4.78M | -5.16M | -6.17M | -6.84M | -7.3M | -7.82M | -8.98M | -9.78M | -10.73M | -11.99M | -13.1M | -13.85M | -14.92M | -16.14M | -18.22M | -19.67M | -9.24M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 6.95M | 7.4M | 3.96M | 4.45M | 5.12M | 6.01M | 7.04M | 7.45M | 8.68M | 9.8M | 10.89M | 11.88M | 12.86M | 13.65M | 14.52M | 15.19M | 16.92M | 18.39M | 20.16M | 9.95M |
| Equity Growth % | 35.67% | 23.12% | -43.78% | -40.23% | -40.96% | -38.67% | -35.4% | -37.31% | -32.52% | -28.22% | -24.99% | -21.8% | -24% | -25.81% | -27.98% | 52.67% | 54.58% | 50.58% | 154.98% | -35.22% |
| Book Value per Share | 3.03 | 3.23 | 2.57 | 2.89 | 3.32 | 3.90 | 4.56 | 4.83 | 5.63 | 6.37 | 7.11 | 7.79 | 8.48 | 9.00 | 11.41 | 11.94 | 13.30 | 18.00 | 19.84 | 11.37 |
| Total Shareholders' Equity | 6.95M | 7.4M | 3.96M | 4.45M | 5.12M | 6.01M | 7.04M | 7.45M | 8.68M | 9.8M | 10.89M | 11.88M | 12.86M | 13.65M | 14.52M | 15.19M | 16.92M | 18.39M | 20.16M | 9.95M |
| Common Stock | 2.29K | 2.29K | 1.54K | 1.54K | 1.54K | 1.54K | 1.54K | 1.54K | 1.54K | 1.54K | 1.54K | 1.54K | 15.19K | 1.52K | 14.34K | 14.34K | 13.47K | 13.46K | 13.41K | 8.77K |
| Retained Earnings | -200.33M | -199.88M | -199.3M | -198.79M | -198.1M | -197.19M | -196.14M | -195.7M | -194.43M | -193.23M | -192.06M | -191.01M | -189.96M | -189.1M | -187.62M | -186.81M | -184.14M | -182.55M | -180.71M | -179.35M |
| Treasury Stock | -5.28M | -5.28M | -5.28M | -5.28M | -5.28M | -5.28M | -5.28M | -5.28M | -5.28M | -5.28M | -5.28M | -5.28M | -5.28M | -5.28M | -5.28M | -5.28M | -5.28M | -5.28M | -5.28M | -5.28M |
| Accumulated OCI | 253.73K | 253.73K | 253.73K | 253.73K | 253.73K | 253.73K | 253.73K | 253.73K | 253.73K | 253.73K | 253.73K | 253.73K | 253.73K | 253.73K | 253.73K | 253.73K | 253.73K | 253.73K | 253.73K | 253.73K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |